Article
Characterisation of IL-23 receptor antagonists and disease relevant mutants using fluorescent probes
2022-10-18
Abstract excerpt
<title>Abstract</title> <p>Association of single nucleotide polymorphisms in the IL-23 receptor with the several auto-inflammatory diseases, led to the heterodimeric receptor and its cytokine-ligand IL-23, becoming important drug targets. Successful antibody-based therapies directed against the cytokine have been licenced and a new class of small peptide antagonists of the receptor have entered clinical trials. T...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9525f856-7639-5fff-a9a2-cb1279169100
- DOI
- 10.21203/rs.3.rs-2118755/v1
